Feasibility of developing and exporting novel fungal strains for the mould ripened cheese market in Italy

Myconeos开发了突破性的技术来自然培育新的真菌菌株。我们已经应用该技术培育了四十年来蓝纹奶酪市场上第一个新的洛克福尔青霉菌株。这些新菌株是通过英国风格蓝奶酪和英国消费者工作的评估而选择的。这四种新的英国商业品种提供了所需的感官属性，以吸引新的消费者进入这一类别，并解决了目前现有品种无法获得的感官特征，例如没有苦味或白垩口感的温和蓝纹奶酪和强烈的蓝纹奶酪。英国市场只占全球蓝纹奶酪销售额的5%，欧洲大陆和北美市场的机会很大。三个欧洲国家占生产和销售的大部分，而Myconeos的目标是意大利。我们将探索为意大利和欧洲的霉菌成熟奶酪市场生产新的真菌菌株的可行性，重点是戈尔贡左拉奶酪和dolcelatte奶酪。制造这些蓝纹奶酪需要比斯蒂尔顿和其他英式蓝纹奶酪更长的成熟时间。因此，可能需要生长速度较慢、蛋白质水解能力较低的新菌株。通过与意大利潜在合作伙伴的合作，Myconeos将更好地了解制造商和消费者的市场需求和机会，并对下一代真菌菌株进行重点研究和开发，同时强调新菌株开发可能满足的未满足需求。附加价值将是将SACCO和IGEA视为潜在的收费制造商和进一步的全球销售和分销合作伙伴。

Myconeos has developed ground breaking technology to naturally breed new fungal strains. We have applied the technology to breed the first new penicillium roqueforti strains in the market for blue cheese application in forty years. These new strains have been selected through evaluation in UK style blue cheeses and consumer work in the UK. The four new UK commercial strains provide desired sensory attributes to attract new consumers into the category and address sensory profiles currently unobtainable with the established strains examples include a mild flavoured blue cheese without bitterness or a chalky mouthfeel and an intense blue cheese. The UK market only accounts for 5% of the blue cheese sales worldwide with the big opportunities being mainland Europe and north america. Three European countries account for the majority of production and sales and Myconeos is targetting Italy. We will explore the feasibility of producing new strains of fungi for the mould ripened cheese market in Italy and Europe with a focus on gorgonzola and dolcelatte. Manufacturing of these blue cheese requires significantly longer maturation times than Stiltons and other UK style blue cheeses. Thus new strains that have reduced growth rates and lower proteolysis maybe needed. Through engagement with potential partners in Italy, Myconeos will better understand the market needs and opportunities at both manufacturers and with consumers and develop a focussed research and development for the next generation fungal strains and also highlight those unmet needs that new strain development could potentially meet. Added value will be to look at SACCO and IGEA as a potential toll manufacturers and further sales and distribution partners for global sales.